Kelley Weinfurtner, MD
Instructor of Medicine, University of Pennsylvania
Department: Medicine
Contact information
421 Curie Blvd, 910 BRB II/III
Philadelphia, PA 19104
Philadelphia, PA 19104
Education:
BA (Bachelor of Arts, Molecular and Cell Biology)
University of California Berkeley, 2007.
MD (Doctor of Medicine)
University of California San Francisco, 2015.
MSTR (Translational Research)
University of Pennsylvania, 2024.
Permanent linkBA (Bachelor of Arts, Molecular and Cell Biology)
University of California Berkeley, 2007.
MD (Doctor of Medicine)
University of California San Francisco, 2015.
MSTR (Translational Research)
University of Pennsylvania, 2024.
Selected Publications
Kelley Weinfurtner, David Tischfield, George McClung, Jennifer Crainic, John Gordan, Jing Jiao, Emma E. Furth, Wuyan Li, Erena Tuzneen Supan, Gregory J. Nadolski, Stephen J. Hunt, David E. Kaplan, Terence P.F. Gade: Human GM-CSF/IL-3 enhance tumor immune infiltration in humanized HCC patient-derived xenografts. JHep Reports 7(3): 101264, March 2025 Notes: https://doi.org/10.1016/j.jhepr.2024.101264.Willis E, Verrelle J, Secreto A, Cole S, McClung G, Weinfurtner K, Gade TP, Radaelli E: Diagnostic Challenge in Veterinary Pathology: Otitis Media in a Humanized NOG-EXL Mouse. Vet Pathol 62(2): 113-116, March 2025.
Huang L, Dang QA, Wright, C, Gade TPF, Weinfurtner, K: Comparison of treatment response to chemoembolization and radioembolization in patients with intermediate stage hepatocellular carcinoma. Society of Interventional Oncology Annual Meeting February 2025 Notes: POSTER.
Hoteit M, Weinfurtner K: Recurrent hepatocellular carcinoma after liver transplantation: Small steps, while awaiting a breakthrough. Liver Transplantation 2025 Notes: Online ahead of print. doi: 10.1097/LVT.0000000000000571.
Habibollahi P, Gurevich A, Hui JZ, Weinfurtner K, McClung G, Adler J, Soulen MC, Kaplan DE, Nadolski GJ, Hunt SJ, Tsourkas A, and Gade TP: Integrated imaging probe and bispecific antibody development enables in vivo targeting of glypican-3-expressiong hepatocellular carcinoma. Mol Cancer Ther 23(12): 1815-1826, December 2024.
Wong JC, Weinfurtner KM, Westover T, Kim J, Lebish EJ, Alzamora Mdel, Walsh M, Abdelhamed S, Ma J, Klco JM, Shannon K. : 5G2 mutant mice model loss of commonly deleted segment of chromosome 7q22 in myeloid malignancies. Leukemia 38(5): 1182-1186, May 2024.
Nicole Ferrante, Rebecca Hubbard, Kelley Weinfurtner, Anya I Mezina, Craig Newcomb, Emma E Furth, Debika Bhattacharya, Basile Njel, Tamar H Taddei, Amit G Singal, Maarouf Hoteit, Lesley S Park, David E Kaplan, Vincent Lo Re: Development and validation of case-finding algorithms to identify cholangiocarcinoma and its subtypes in Veterans Health Administration data. Digestive Disease Week May 2024 Notes: POSTER.
Quynh-Anh L Dang, Kelley Weinfurtner, Gregory J Nadolski, Stephen J Hunt, Terence P Gade: Prolonged Treatment Response With Radioembolization Compared to Chemoembolization in Early Stage Hepatocellular Carcinoma Patients Ineligible for Curative Therapy. SIR Annual Meeting March 2024 Notes: POSTER.
Weinfurtner K, Kurian M, Ackerman D, Woodard A, Li W, Crainic J, Soulen MC, Dagli M, Shamimi-Noori S, Mondschein J, Sudheendra D, Stavropoulos SW, Reddy S, Khaddash T, Further EE, Siegelman ES, Hunt SJ, Nadolski GJ, Kaplan DE, Gade TPF : Activating B-catenin pathway mutations predict favorable outcomes after transarterial chemoembolization in unresectable hepatocellular carcinoma. ILCA Annual Meeting September 2023 Notes: POSTER.
Weinfurtner K, Kurian M, Ackerman D, Woodard A, Li W, Crainic J, Soulen MC, Dagli M, Shamimi-Noori S, Mondschein J, Sudheendra D, Stavropoulos SW, Reddy S, Khaddash T, Further EE, Siegelman ES, Hunt SJ, Nadolski GJ, Kaplan DE, Gade TPF : B-catenin pathway mutations predict favorable outcome after transarterial chemoembolization in unresectable hepatocellular carcinoma AASLD Liver Meeting November 2022 Notes: POSTER.